3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
28
Neoplasm Metastasis
9
Neoplasms
8
Brain Neoplasms
5
Triple Negative Breast Neoplasms
3
Recurrence
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasms by Site
3
Glioma
3
Endometrial Neoplasms
3
Breast Diseases
3
Squamous Cell Carcinoma of Head and Neck
2
Liposarcoma
2
Head and Neck Neoplasms
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Sarcoma
1
Recurrent Ovarian High Grade Serous Adenocarcinoma
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neurofibromatosis 1
1
Neoplasms, Squamous Cell
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Interventions
venetoclax
28
Rituximab
22
ibrutinib
21
acalabrutinib
21
Cyclophosphamide
20
Specimen Handling
18
obinutuzumab
15
Biopsy
14
fludarabine
13
zanubrutinib
10
pirtobrutinib
10
fludarabine phosphate
9
Magnetic Resonance Spectroscopy
8
Bendamustine Hydrochloride
8
idelalisib
6
Whole-Body Irradiation
6
Mycophenolic Acid
6
Lenalidomide
6
CT-P10
6
ARQ531
6
Cyclosporine
5
Sirolimus
4
Peripheral Blood Stem Cell Transplantation
4
pembrolizumab
3
Vincristine
3
Tacrolimus
3
Prednisone
3
Doxorubicin
3
Disulfides
3
Cyclosporins
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphocytic, Chronic, B-Cell
×
abemaciclib
×
90 days
×
Clear all
No trials found.